Skip to main content
GutCited

Beschreibung

Patient-reported global satisfaction with treatment outcomes is compared between the synbiotic and placebo groups.

Figure 15

Chart

Source Paper

The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant …

Nutrients (2020)

PMID: 32635661

DOI: 10.3390/nu12071999

Cite This Figure

![Figure 15: Patient-reported global satisfaction with treatment outcomes is compared between the synbiotic and placebo groups.]()

> Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." *Nutrients*, 2020. PMID: [32635661](https://pubmed.ncbi.nlm.nih.gov/32635661/)
<figure>
  <img src="" alt="Patient-reported global satisfaction with treatment outcomes is compared between the synbiotic and placebo groups." />
  <figcaption>Figure 15. Patient-reported global satisfaction with treatment outcomes is compared between the synbiotic and placebo groups.<br>  Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32635661/">32635661</a></figcaption>
</figure>

Verwandte Evidenz

B
Bifidobacterium longum für Irritable Bowel Syndrome (IBS)

Bewertung B · 4 Studien

 B
Galactooligosaccharides (GOS) für Irritable Bowel Syndrome (IBS)

Bewertung B · 3 Studien

 B
Lactobacillus acidophilus für Irritable Bowel Syndrome (IBS)

Bewertung B · 3 Studien

 D
Fructooligosaccharides (FOS) für Irritable Bowel Syndrome (IBS)

Bewertung D · 2 Studien